Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs138479608 | chr12:56653914 | G/C | 1.09E-7 | 177 | 25.17 | 27.33 | 0.8 | KM Plot |
PCPG | rs138502968 | chr2:24323106 | A/G | 0.000114 | 177 | 25.4 | 26.92 | 17.43 | KM Plot |
PCPG | rs138529886 | chr12:53505014 | T/C | 1.19E-10 | 174 | 25.08 | 27.08 | 3.05 | KM Plot |
PCPG | rs138540086 | chr12:56653294 | G/A | 1.09E-7 | 177 | 25.17 | 27.33 | 0.8 | KM Plot |
PCPG | rs138578576 | chr22:50204808 | CA/C | 0.000162 | 176 | 25.77 | 23.88 | 15.18 | KM Plot |
PCPG | rs138610644 | chr14:74589604 | A/AAAAAC | 4.4E-7 | 177 | 25.4 | 27.78 | 7.4 | KM Plot |
PCPG | rs138944585 | chr16:90111348 | T/TAACTC | 9.88E-9 | 175 | 25.77 | 20.2 | 6.62 | KM Plot |
PCPG | rs138948373 | chr2:176149228 | T/TA | 0.000139 | 175 | 25.28 | 28.47 | 6.62 | KM Plot |
PCPG | rs139068486 | chr2:136535235 | T/A | 3.13E-5 | 174 | 25.87 | 25.87 | 9.72 | KM Plot |
PCPG | rs139146977 | chr2:239088825 | G/GAAAGAA | 3.06E-5 | 171 | 28.95 | 18.2 | 13.22 | KM Plot |
PCPG | rs139271236 | chr7:105162336 | A/G | 5.12E-5 | 178 | 20.2 | 29.43 | 2.28 | KM Plot |
PCPG | rs139276547 | chr13:37629133 | A/G | 0.000367 | 175 | 25.87 | 24.23 | 4.17 | KM Plot |
PCPG | rs1393644 | chr4:78956707 | C/A | 0 | 176 | 2.93 | 25.87 | 25.28 | KM Plot |
PCPG | rs139479123 | chr7:105164932 | C/T | 5.12E-5 | 178 | 20.2 | 29.43 | 2.28 | KM Plot |
PCPG | rs139483757 | chr7:105165282 | A/ACT | 5.12E-5 | 178 | 20.2 | 29.43 | 2.28 | KM Plot |